Tag: Obesity
Few Adolescents With Obesity Prescribed Obesity Medications
0.5 percent with obesity were prescribed an obesity medication in 2023; 83 percent of prescriptions received by teens with severe obesity
Doctors Favor CPAP, Patients Favor Tirzepatide for Comorbid Obesity, Sleep Apnea
If evidence demonstrates equal effectiveness, providers favor CPAP, while patients lean toward tirzepatide
Obesity Linked to Subsequent Neoplasms in Childhood Cancer Survivors
Higher physical activity was associated with reduced subsequent neoplasm risk overall and for specific cancers
Maternal Obesity Linked to Pediatric Hospital Admissions for Infection
Children born to women with obesity grades 2 and 3 have increased rate ratio for hospital admission for infection at <1, 5 to 15 years
ASCO: GLP-1 Receptor Agonists May Reduce Risk for Obesity-Related Cancer, All-Cause Death
Protective association seen between GLP-1 receptor agonist use and colon and rectal cancers in adults with obesity and diabetes
Post-Kidney Transplant Adverse Outcomes Increased With BMI-BSA Obesity
Risks were significantly greater than when body mass index and body surface area were discordant
Novo Nordisk, U.S. Biotech Company Team Up to Create Obesity Pills
Risk of Obesity-Related Cancer Similar for GLP-1 Receptor Agonists and Bariatric Surgery
Findings for matched groups of patients with obesity and diabetes taking first-generation GLP-1 RA or undergoing bariatric metabolic surgery
Metabolic and Bariatric Surgery Increased in Adolescents From 2021 to 2023
Findings seen despite a downward trend in adults and the approval of second-generation antiobesity medications
GLP-1 Receptor Agonists Reduce Alcohol Intake in Patients Treated for Obesity
Reductions in alcohol intake noted in high and low consumers; no significant difference seen in percentage reductions for men and women
